The hyperlipoproteinemias

W. Patsch, J. R. Patsch, A. M. Gotto

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

The association of disturbances of plasma lipid transport and atherogenesis has been recognized, and scientific data continue to accumulate to explain this association from a mechanistic viewpoint. A number of recent clinical trials have shown that cholesterol-lowering therapy can prevent the complications of atherosclerosis. Consequently, the attention of physicians to therapeutic intervention has increased and public awareness to plasma cholesterol levels has been heightened. This article summarizes current knowledge of how plasma lipid transport is regulated. The classical primary hyperlipoproteinemias are considered and hyperlipoproteinemias occurring secondary to other diseases are discussed. Standard methods to diagnose the defined genetic hyperlipidemias are outlined, and new approaches to assess risk of atherosclerosis are examined. Finally, the role of dietary measures and drugs in lowering blood lipids and reducing risk of coronary heart disease is delineated.

Original languageEnglish (US)
Pages (from-to)859-893
Number of pages35
JournalMedical Clinics of North America
Volume73
Issue number4
DOIs
StatePublished - 1989

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The hyperlipoproteinemias'. Together they form a unique fingerprint.

Cite this